Table 7 Effect of FVBM , F18 bioactive compound and atorvastatin on plasma LDL-C, HDL-C and VLDL-C in Triton WR-1339 induced hyperlipidemic rats after 18 hours of treatment

NC

35.5 ± 1.12*

27.5 ± 0.99

12 ± 0.67

HLC

280.12 ± 4.36*

22.28 ± 0.56

48.26 ± 1.45

(+646.66%)^a

(−20%)^a

(+300.04%)^a

FVT-1

81.15 ± 2.19*

26.63 ± 0.74

19.09 ± 0.81

(−71.07%)^a

(+19.3%)^a

(−60.41%)^a

FVT-2

39.5 ± 1.37*

29.7 ± 1.15

13.08 ± 0.64

(−85.89%)^a

(+35%)^a

(−71.40%)^a

CT

43.26 ± 1.25*

28.2 ± 1.14

12.54 ± 0.63

(−84.55%)^a

(+28.18%)^a

(−74.01%)^a

AT

37.88 ± 1.18*

28.4 ± 1.15

11.72 ± 0.52

(−86.47%)^a

(+29.09%)^a

(−75.71%)^a